Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | PYGM | P11217 | 3/20 | 0.40 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.38 |
| ▸ | CA12 | O43570 | 3/20 | 0.37 |
| ▸ | CA9 | Q16790 | 3/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| D-Galactose SCHEMBL16581344 | 1.00 | ATAD2 (0.53) | ATAD2ALDH1A1PYGMSLC5A2CA12 | |
| Ribose (Furanose) SCHEMBL5521544 | 0.99 | ATAD2 (0.54) | ATAD2ALDH1A1PYGMSLC5A2CA12 | |
| Ribose (Furanose) SCHEMBL1851842 | 0.99 | ATAD2 (0.54) | ATAD2ALDH1A1PYGMSLC5A2CA12 | |
| Ribose (Furanose) SCHEMBL9621710 | 0.83 | SLC5A2 (0.39) | ALDH1A1PYGMSLC5A2SLC5A1 | |
| Ribose (Furanose) SCHEMBL27814247 | 0.82 | DPYD (0.54) | ALDH1A1PYGMATM | |
| Ribose (Furanose) SCHEMBL2056776 | 0.82 | LMNA (0.54) | ALDH1A1PYGMATM | |
| Ribose (Furanose) SCHEMBL3976341 | 0.82 | LMNA (0.54) | ALDH1A1PYGMATM | |
| Thymine SCHEMBL4201976 | 0.78 | ATAD2 (0.50) | ATAD2ALDH1A1 | |
| SCHEMBL28396302 | 0.76 | PNP (0.44) | ALDH1A1PYGMSLC5A2ATM | |
| SCHEMBL30525201 | 0.76 | PNP (0.44) | ALDH1A1PYGMSLC5A2ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040033967-A1 | Alkylated hexitol nucleoside analogues and oligomers thereof | K.U.LEUVEN RESEARCH AND DEVELOPMENT (BE) | 2004-02-19 | — | — | US | disclosed |
| WO-2002018406-A1 | ALKYLATED HEXITOL NUCLEOSIDE ANALOGUES AND OLIGOMERS THEREOF | K.U.LEUVEN RESEARCH AND DEVELOPMENT (BE) | 2002-03-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040033967-A1 | Alkylated hexitol nucleoside analogues and oligomers thereof | DERA, HEXA, HEXB | ATAD2 1385/4885ALDH1A1 1202/4885PYGM 1392/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.